GlobeNewswire: LipoScience, Inc. Contains the last 10 of 28 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T07:04:43ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2014/11/12/682385/10107672/en/LipoScience-Announces-2014-Third-Quarter-Financial-Results.html?f=22&fvtc=4&fvtv=18700LipoScience Announces 2014 Third Quarter Financial Results2014-11-12T12:00:00Z<![CDATA[RALEIGH, N.C., Nov. 12, 2014 (GLOBE NEWSWIRE) -- ]]>https://www.globenewswire.com/news-release/2014/10/15/673519/10102823/en/LabCorp-s-Acquisition-of-LipoScience-Clears-Antitrust-Approval.html?f=22&fvtc=4&fvtv=18700LabCorp's Acquisition of LipoScience Clears Antitrust Approval2014-10-15T20:05:00Z<![CDATA[RALEIGH, N.C., Oct. 15, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the acquisition of LipoScience by Laboratory Corporation of America]]>https://www.globenewswire.com/news-release/2014/09/25/668416/10099986/en/LabCorp-Announces-Agreement-to-Acquire-LipoScience.html?f=22&fvtc=4&fvtv=18700LabCorp Announces Agreement to Acquire LipoScience2014-09-25T10:55:00Z<![CDATA[Acquisition Price of $5.25 Per Share in All Cash Transaction
NMR LipoProfile test expands LabCorp's offering of personalized diagnostic tests]]>https://www.globenewswire.com/news-release/2014/08/12/658104/10094358/en/LipoScience-Announces-2014-Second-Quarter-Financial-Results.html?f=22&fvtc=4&fvtv=18700LipoScience Announces 2014 Second Quarter Financial Results2014-08-12T20:01:00Z<![CDATA[Achieves Second Quarter Revenue Guidance
Healthcore Study Provides Compelling Data on Reduction in Cardiovascular Disease Risk and Events]]>https://www.globenewswire.com/news-release/2014/08/04/655863/10092849/en/LipoScience-to-Release-Second-Quarter-2014-Financial-Results.html?f=22&fvtc=4&fvtv=18700LipoScience to Release Second Quarter 2014 Financial Results2014-08-04T20:15:00Z<![CDATA[RALEIGH, N.C., Aug. 4, 2014 (GLOBE NEWSWIRE) -- ]]>https://www.globenewswire.com/news-release/2014/05/12/635559/10081216/en/LipoScience-Announces-2014-First-Quarter-Financial-Results.html?f=22&fvtc=4&fvtv=18700LipoScience Announces 2014 First Quarter Financial Results2014-05-12T20:05:00Z<![CDATA[RALEIGH, N.C., May 12, 2014 (GLOBE NEWSWIRE) -- ]]>https://www.globenewswire.com/news-release/2014/05/05/632882/10079860/en/LipoScience-Announces-Cash-Management-Actions.html?f=22&fvtc=4&fvtv=18700LipoScience Announces Cash Management Actions2014-05-05T10:30:00Z<![CDATA[RALEIGH, N.C., May 5, 2014 (GLOBE NEWSWIRE) -- In a proactive effort to manage its cash, ]]>https://www.globenewswire.com/news-release/2014/04/28/630688/10078577/en/LipoScience-to-Release-First-Quarter-2014-Financial-Results.html?f=22&fvtc=4&fvtv=18700LipoScience to Release First Quarter 2014 Financial Results2014-04-28T20:05:00Z<![CDATA[RALEIGH, N.C., April 28, 2014 (GLOBE NEWSWIRE) -- ]]>https://www.globenewswire.com/news-release/2014/03/28/622323/10074373/en/LipoScience-Announces-Termination-of-Contract-With-Health-Diagnostics-Laboratory.html?f=22&fvtc=4&fvtv=18700LipoScience Announces Termination of Contract With Health Diagnostics Laboratory2014-03-28T10:45:00Z<![CDATA[First Quarter 2014 Revenue Outlook Update RALEIGH, N.C., March 28, 2014 (GLOBE NEWSWIRE) -- LipoScience, Inc. (Nasdaq:LPDX) today announced the termination of its relationship with Health Diagnostics Laboratory, Inc. ("HDL Inc."), one of its laboratory customers. On March 17, 2014, HDL Inc. began offering its own non-FDA cleared test for the measurement of low density lipoprotein particles ("LDL-P"). While the ]]>https://www.globenewswire.com/news-release/2014/03/10/617169/10071994/en/LipoScience-Announces-2013-Fourth-Quarter-and-Full-Year-Financial-Results.html?f=22&fvtc=4&fvtv=18700LipoScience Announces 2013 Fourth Quarter and Full Year Financial Results2014-03-10T20:05:00Z<![CDATA[RALEIGH, N.C., March 10, 2014 (GLOBE NEWSWIRE) -- ]]>